Serine Market Expected to Reach $60.5 Million by 2032—Allied Market Research

According to a new report published by Allied Market Research, titled, “Serine Market," The serine market was valued at $33.30 million in 2022, and is estimated to reach $60.5 million by 2032, growing at a CAGR of 6.2% from 2023 to 2032.

Serine is a necessary amino acid characterized by its chemical structure comprising an amino group, a carboxyl group, and a hydroxyl crew in its facet chain. It serves as a fundamental constructing block for proteins and plays vast roles in metabolic pathways, mobile signaling, and neurotransmitter synthesis.

Serine has famous hydrophilic properties due to its hydroxyl group, making it soluble in water. It is an optically energetic compound, existing in both D- and L- forms. Serine is necessary for retaining protein structure and function, cell membrane integrity, and suitable neuronal communication, highlighting its importance in biological processes.

The increasing meals and beverage industry is a principal using force at the back of the increase of the serine market. Serine, an amino acid, performs a quintessential role in various organic methods and is used as a key ingredient in food and beverage products. The market for serine has witnessed huge growth with the extent of demand for functional food and dietary supplements. Serine is regarded for its practicable fitness benefits, including its position in protein synthesis, muscle growth, and immune device support.

Furthermore, it is extensively used as a flavor enhancer and a herbal ingredient in meals and beverage formulations. As the food and beverage industry continues to expand, the demand for serine is predicted to rise, using the boom of the serine market.

Volatility in raw fabric expenditures can extensively impede the serine market. Serine manufacturing depends on raw materials such as soybeans, which are difficult to rate fluctuations due to more than a few factors. Unpredictable weather conditions, modifications in global demand, and geopolitical occasions can all have an effect on the availability and cost of these raw materials. When raw material expenditures grow to be volatile, it can disrupt the cost shape of serine manufacturers, leading to improved manufacturing costs. As a result, producers may additionally pass these costs onto consumers, which can affect demand for serine-based products.

Additionally, volatile raw material expenditures make it challenging for manufacturers to forecast and graph production, probably leading to supply shortages or extra inventory. Overall, the volatility in raw material costs acts as a considerable restraint on the serine market, impacting its steadiness and growth.

Serine plays an integral function in the manufacturing of biopharmaceuticals, including monoclonal antibodies, recombinant proteins, and vaccines. It is used as a stabilizing agent and nutrient in cell culture media for the growth of mammalian cell lines. With the non-stop increase of the biotechnology and biopharmaceutical sectors, the demand for serine as a necessary factor in bioprocessing is expected to rise. This creates a favorable market outlook for serine suppliers, who can cater to the growing need for remarkable serine in the manufacturing of advanced therapeutics and bio-based drugs. Therefore, the increasing field of biotechnology and biopharmaceuticals presents lucrative opportunities for the serine market.

The serine market is segmented on the basis of product type, end-use industry, and region. By product type, the market is divided into L serine, D serine, and DL serine. On the basis of the end-use industry, it is categorized into food and beverages, pharmaceuticals, cosmetics and personal care, agriculture, animal feed and nutrition, and others. Region-wise, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.

On the basis of product type, the serine market is categorized into L serine, D serine, and DL serine. L Serine is projected to be the fastest-growing segment and has garnered the highest share of the serine market.

On the basis of the end-use industry, the serine market is classified into food and beverages, pharmaceuticals, cosmetics and personal care, agriculture, animal feed and nutrition, and others. Pharmaceuticals are projected to be the fastest-growing segment and have garnered the highest share in the serine market.

The major players operating in the global serine market are Ajinomoto Co., Inc., Evonik Industries AG, Mitsui Chemicals, Inc., Thermo Fisher Scientific Inc., Sichuan Tongsheng Amino acid Co., Ltd ., Shanghai Brightol International Co, Ltd., Kyowa Hakko Bio Co., Ltd., Suvchem, Merck KGaA and Tokyo Chemical Industry Co., Ltd. (TCI).

Other players include BASF SE, Biosynth Carbosynth, MP Biomedicals LLC, Hunan Huacheng Biotech, Inc., Nanjing Vital Chemical Co., Ltd., Toronto Research Chemicals Inc., Cayman Chemical Company, Santa Cruz Biotechnology, Inc., Enzo Life Sciences, Inc., Apollo Scientific Ltd., Chem-Impex International, Inc., and others.

Key findings of the study

• On the basis of product type, The L serine segment is expected to grow at a CAGR of 6.4%, in terms of revenue, during the forecast period.
• Depending on the end-use industry, the pharmaceuticals segment is expected to grow at a CAGR of 6.6%, in terms of revenue, during the forecast period.
• Region-wise, North America garnered a major share in 2022 in terms of revenue.